# | Title | Journal | Year | Citations |
---|
1 | Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis | Lancet, The | 2018 | 452 |
2 | Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1 | New England Journal of Medicine | 2019 | 203 |
3 | The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease | Frontiers in Immunology | 2018 | 162 |
4 | Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts | Annual Review of Immunology | 2018 | 151 |
5 | SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery | Blood | 2018 | 128 |
6 | PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis | Science | 2020 | 110 |
7 | Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy‐candidiasis‐ectodermal dystrophy | Immunological Reviews | 2019 | 108 |
8 | Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring | Science | 2021 | 108 |
9 | Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells | Nature Immunology | 2022 | 105 |
10 | Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions | Clinical Infectious Diseases | 2018 | 82 |
11 | Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier | Science | 2021 | 75 |
12 | Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection | Journal of Infectious Diseases | 2019 | 72 |
13 | The present state of the tuberculosis drug development pipeline | Current Opinion in Pharmacology | 2018 | 70 |
14 | Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design | Cell | 2018 | 67 |
15 | A New Lineage of Cryptococcus gattii (VGV) Discovered in the Central Zambezian Miombo Woodlands | MBio | 2019 | 66 |
16 | Architecture of the human PI4KIIIα lipid kinase complex | Proceedings of the National Academy of Sciences of the United States of America | 2017 | 54 |
17 | Invasive Candidiasis Species Distribution and Trends, United States, 2009–2017 | Journal of Infectious Diseases | 2021 | 51 |
18 | Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells | Blood | 2021 | 51 |
19 | Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation | Science Immunology | 2021 | 50 |
20 | 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization | ACS Infectious Diseases | 2018 | 49 |
21 | Systemic Type I IFN Inflammation in Human ISG15 Deficiency Leads to Necrotizing Skin Lesions | Cell Reports | 2020 | 47 |
22 | Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment | Antimicrobial Agents and Chemotherapy | 2018 | 43 |
23 | Current and future treatments for tuberculosis | BMJ, The | 2020 | 43 |
24 | Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT | Journal of Clinical Immunology | 2019 | 41 |
25 | Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair | Gene Therapy | 2021 | 39 |
26 | Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice | Journal of Experimental Medicine | 2021 | 38 |
27 | Editorial: NK Cell Subsets in Health and Disease: New Developments | Frontiers in Immunology | 2017 | 35 |
28 | The microbiome and immunodeficiencies: Lessons from rare diseases | Journal of Autoimmunity | 2019 | 35 |
29 | Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors | Current Fungal Infection Reports | 2019 | 34 |
30 | Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis | Journal of Clinical Immunology | 2020 | 33 |
31 | Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches | Journal of Medicinal Chemistry | 2019 | 32 |
32 | RELA haploinsufficiency in CD4 lymphoproliferative disease with autoimmune cytopenias | Journal of Allergy and Clinical Immunology | 2018 | 31 |
33 | The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS | Annals of the Rheumatic Diseases | 2022 | 31 |
34 | Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase | Journal of Medicinal Chemistry | 2018 | 29 |
35 | Emerging Aspergillus Species Almost Exclusively Associated With Primary Immunodeficiencies | Open Forum Infectious Diseases | 2018 | 28 |
36 | Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections | Clinical Immunology | 2019 | 27 |
37 | Organ-specific mechanisms linking innate and adaptive antifungal immunity | Seminars in Cell and Developmental Biology | 2019 | 27 |
38 | APECED‐Associated Hepatitis: Clinical, Biochemical, Histological and Treatment Data From a Large, Predominantly American Cohort | Hepatology | 2021 | 25 |
39 | Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis | Science Translational Medicine | 2021 | 25 |
40 | GM-CSF therapy in human caspase recruitment domain–containing protein 9 deficiency | Journal of Allergy and Clinical Immunology | 2018 | 24 |
41 | Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)? | Clinical Infectious Diseases | 2021 | 24 |
42 | Migration-induced cell shattering due to DOCK8 deficiency causes a type 2–biased helper T cell response | Nature Immunology | 2020 | 21 |
43 | Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification | Nucleic Acids Research | 2020 | 20 |
44 | Structural Basis for a Dual Function ATP Grasp Ligase That Installs Single and Bicyclic ω-Ester Macrocycles in a New Multicore RiPP Natural Product | Journal of the American Chemical Society | 2021 | 20 |
45 | Protective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model | Journal of Infectious Diseases | 2020 | 19 |
46 | Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies | Journal of Allergy and Clinical Immunology | 2022 | 19 |
47 | Profiling Autoantibodies against Salivary Proteins in Sicca Conditions | Journal of Dental Research | 2019 | 18 |
48 | Unique molecular signature in mucolipidosis type IV microglia | Journal of Neuroinflammation | 2019 | 17 |
49 | Idebenone does not inhibit disability progression in primary progressive MS | Multiple Sclerosis and Related Disorders | 2020 | 17 |
50 | IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease | Human Genetics | 2021 | 17 |